Literature DB >> 11586001

Optimal treatment strategies for community-acquired pneumonia: non-responders to conventional regimens.

T M File1.   

Abstract

When patients with community-acquired pneumonia (CAP) fail to respond after initiation of empirical therapy, it is necessary for the physician to consider a number of possibilities. The diagnosis should be reviewed, with consideration given to both non-infectious and infectious illnesses. If the diagnosis is correct, the failure may relate to three areas: host-related problems, including overwhelming infection and empyema, pathogen-related problems, including infection caused by an unusual or resistant pathogen, and drug-related problems, including inappropriate dose of drug, poor compliance, malabsorption, and drug interactions. A systematic therapeutic approach including a microbiological evaluation to identify the causative pathogen and its susceptibility will help to ensure that an appropriate antimicrobial agent is used. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586001     DOI: 10.1159/000049175

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  2 in total

Review 1.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

2.  Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia.

Authors:  Sarah Berger; Cengiz Goekeri; Shishir K Gupta; Julio Vera; Kristina Dietert; Ulrike Behrendt; Jasmin Lienau; Sandra-Maria Wienhold; Achim D Gruber; Norbert Suttorp; Martin Witzenrath; Geraldine Nouailles
Journal:  Crit Care       Date:  2018-11-01       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.